VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Celsius Holdings, Inc. vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Celsius Holdings, Inc.
CELH · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Celsius Holdings, Inc.'s moat claims, evidence, and risks.
View CELH analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: GSK plc leads (62 / 100 vs 57 / 100 for Celsius Holdings, Inc.).
- Segment focus: Celsius Holdings, Inc. has 1 segment (100% in Functional Energy Beverages (CELSIUS, Alani Nu, Rockstar)); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Celsius Holdings, Inc. has 3 moat types across 2 domains; GSK plc has 4 across 3.
Primary market context
Celsius Holdings, Inc.
Functional Energy Beverages (CELSIUS, Alani Nu, Rockstar)
Energy drinks (functional/better-for-you positioning) and adjacent wellness products
Primarily North America; growing international presence
Consumers via retail and e-commerce channels; sold through distributor/retail channels
Brand owner / product developer; uses third-party manufacturing and third-party distribution
100%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Celsius Holdings, Inc. strengths
GSK plc strengths
Segment mix
Celsius Holdings, Inc. segments
Full profile >Functional Energy Beverages (CELSIUS, Alani Nu, Rockstar)
Oligopoly
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.